Pulmonary Hypertension Related to Chronic Obstructive Pulmonary Disease and Diffuse Parenchymal Lung Disease A Focus on Right Ventricular (Dys) Function

作者：Tseng Steve; Stanziola Anna Agnese; Sultan Samir; Henry Kyle; Saggar Rajeev^*; Saggar Rajan^*

来源：Heart Failure Clinics, 2018, 14(3): 403-+.

DOI：10.1016/j.hfc.2018.03.006

• Pulmonary hypertension
• Pulmonary fibrosis
• COPD
• Right ventricular dysfunction
• Diffuse pulmonary lung disease

Diffuse pulmonary lung disease and chronic obstructive pulmonary disease is a heterogeneous population that can manifest pulmonary hypertension. These subgroups are classified as primarily World Health Organization group 3. Available data suggest that the impact of pulmonary hypertension targeted therapy in diffuse pulmonary lung disease and chronic obstructive pulmonary disease is limited and survival is poor despite attempted treatment.

• 出版日期2018-7